长链非编码RNA H19通过驱动HDAC1依赖的M1小胶质细胞极化促进缺血性卒中神经炎症
该研究探讨长链非编码RNA H19在缺血性卒中后的作用及机制。卒中患者循环H19水平显著高于健康对照,且与NIHSS评分和TNF-α正相关。小鼠脑缺血后H19升高,敲低H19可减小梗死体积和脑水肿、减轻神经功能缺损,并抑制氧糖剥夺驱动的M1小胶质细胞极化,其效应由HDAC1介导。
要点
- 卒中患者循环H19升高,与NIHSS评分及TNF-α正相关。
- 小鼠脑缺血后血浆、白细胞和脑内H19水平升高。
- 敲低H19减轻缺血性损伤和神经炎症,抑制M1极化。
核心结论
- H19通过驱动HDAC1依赖的M1小胶质细胞极化促进缺血性卒中神经炎症。
- H19可能作为缺血性卒中的新型诊断和治疗靶点。
研究设计与样本
- 检测卒中患者和小鼠大脑中动脉闭塞模型的循环H19水平。
- 使用H19 siRNA敲低H19、HDAC1质粒过表达HDAC1。
- 在MCAO小鼠和氧糖剥夺BV2小胶质细胞中评估小胶质细胞极化和缺血结局。
主要发现
- 卒中患者循环H19水平显著高于健康对照,具有高诊断敏感性和特异性。
- 血浆H19水平与NIHSS评分和TNF-α水平正相关。
- 小鼠MCAO后血浆、白细胞和脑内H19水平升高。
- 脑室内注射H19 siRNA减小梗死体积和脑水肿,降低脑组织和血浆TNF-α、IL-1β,升高血浆IL-10(卒中后24小时)。
- H19敲低减轻卒中后14天脑组织丢失和神经功能缺损。
关键数值与推荐
- BV2细胞中H19敲低阻断氧糖剥夺驱动的M1极化,降低TNF-α和CD11b,增加Arg-1和CD206表达。
- H19敲低逆转氧糖剥夺诱导的HDAC1上调和乙酰化组蛋白H3、H4下调。
- HDAC1过表达抵消H19敲低的效果。
临床怎么用
- 循环H19水平可能辅助缺血性卒中的诊断和病情评估。
- 靶向H19-HDAC1轴可能减轻缺血性卒中神经炎症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Long noncoding RNA H19 is repressed after birth, but can be induced by hypoxia. We aim to investigate the impact on and underlying mechanism of H19 induction after ischemic stroke. METHODS: Circulating H19 levels in stroke patients and mice subjected to middle cerebral artery occlusion were assessed using real-time polymerase chain reaction. H19 siRNA and histone deacetylase 1 (HDAC1) plasmid were used to knock down H19 and overexpress HDAC1, respectively. Microglial polarization and ischemic outcomes were assessed in middle cerebral artery occlusion mice and BV2 microglial cells subjected to oxygen-glucose deprivation. RESULTS: Circulating H19 levels were significantly higher in stroke patients compared with healthy controls, indicating high diagnostic sensitivity and specificity. Moreover, plasma H19 levels showed a positive correlation with National Institute of Health Stroke Scale score and tumor necrosis factor-α levels. After middle cerebral artery occlusion in mice, H19 levels increased in plasma, white blood cells, and brain. Intracerebroventricular injection of H19 siRNA reduced infarct volume and brain edema, decreased tumor necrosis factor-α and interleukin-1β levels in brain tissue and plasma, and increased plasma interleukin-10 concentrations 24 hours poststroke. Additionally, H19 knockdown attenuated brain tissue loss and neurological deficits 14 days poststroke. BV2 cell-based experiments showed that H19 knockdown blocked oxygen-glucose deprivation-driven M1 microglial polarization, decreased production of tumor necrosis factor-α and CD11b, and increased the expression of Arg-1 and CD206. Furthermore, H19 knockdown reversed oxygen-glucose deprivation-induced upregulation of HDAC1 and downregulation of acetyl-histone H3 and acetyl-histone H4. In contrast, HDAC1 overexpression negated the effects of H19 knockdown. CONCLUSIONS: Our findings indicate that H19 promotes neuroinflammation by driving HDAC1-dependent M1 microglial polarization, suggesting a novel H19-based diagnosis and therapy for ischemic stroke.
引用
- Wang J, Zhao H, Fan Z, et al. Long Noncoding RNA H19 Promotes Neuroinflammation in Ischemic Stroke by Driving Histone Deacetylase 1-Dependent M1 Microglial Polarization. Stroke. 2017. PMID: 28630232. doi:10.1161/STROKEAHA.117.017387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。